89 related articles for article (PubMed ID: 26264915)
41. E6-AP association promotes SOD1 aggresomes degradation and suppresses toxicity.
Mishra A; Maheshwari M; Chhangani D; Fujimori-Tonou N; Endo F; Joshi AP; Jana NR; Yamanaka K
Neurobiol Aging; 2013 Apr; 34(4):1310.e11-23. PubMed ID: 23040663
[TBL] [Abstract][Full Text] [Related]
42. Pathogenic superoxide dismutase structure, folding, aggregation and turnover.
Hart PJ
Curr Opin Chem Biol; 2006 Apr; 10(2):131-8. PubMed ID: 16516535
[TBL] [Abstract][Full Text] [Related]
43. Regulation of proteasome-mediated protein degradation during oxidative stress and aging.
Breusing N; Grune T
Biol Chem; 2008 Mar; 389(3):203-9. PubMed ID: 18208355
[TBL] [Abstract][Full Text] [Related]
44. Impaired fertilizing ability of superoxide dismutase 1-deficient mouse sperm during in vitro fertilization.
Tsunoda S; Kawano N; Miyado K; Kimura N; Fujii J
Biol Reprod; 2012 Nov; 87(5):121. PubMed ID: 22933517
[TBL] [Abstract][Full Text] [Related]
45. The nuclear proteasome and the degradation of oxidatively damaged proteins.
Voss P; Grune T
Amino Acids; 2007; 32(4):527-34. PubMed ID: 17103119
[TBL] [Abstract][Full Text] [Related]
46. Accelerated impairment of spermatogenic cells in SOD1-knockout mice under heat stress.
Ishii T; Matsuki S; Iuchi Y; Okada F; Toyosaki S; Tomita Y; Ikeda Y; Fujii J
Free Radic Res; 2005 Jul; 39(7):697-705. PubMed ID: 16036348
[TBL] [Abstract][Full Text] [Related]
47. DJ-1 forms complexes with mutant SOD1 and ameliorates its toxicity.
Yamashita S; Mori A; Kimura E; Mita S; Maeda Y; Hirano T; Uchino M
J Neurochem; 2010 May; 113(4):860-70. PubMed ID: 20202083
[TBL] [Abstract][Full Text] [Related]
48. Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress.
Seifert U; Bialy LP; Ebstein F; Bech-Otschir D; Voigt A; Schröter F; Prozorovski T; Lange N; Steffen J; Rieger M; Kuckelkorn U; Aktas O; Kloetzel PM; Krüger E
Cell; 2010 Aug; 142(4):613-24. PubMed ID: 20723761
[TBL] [Abstract][Full Text] [Related]
49. Dorfin-CHIP chimeric proteins potently ubiquitylate and degrade familial ALS-related mutant SOD1 proteins and reduce their cellular toxicity.
Ishigaki S; Niwa J; Yamada S; Takahashi M; Ito T; Sone J; Doyu M; Urano F; Sobue G
Neurobiol Dis; 2007 Feb; 25(2):331-41. PubMed ID: 17157513
[TBL] [Abstract][Full Text] [Related]
50. Erythrocytes as a preferential target of oxidative stress in blood.
Fujii J; Homma T; Kobayashi S; Warang P; Madkaikar M; Mukherjee MB
Free Radic Res; 2021 May; 55(5):562-580. PubMed ID: 33427524
[TBL] [Abstract][Full Text] [Related]
51. FAIM Is a Non-redundant Defender of Cellular Viability in the Face of Heat and Oxidative Stress and Interferes With Accumulation of Stress-Induced Protein Aggregates.
Kaku H; Rothstein TL
Front Mol Biosci; 2020; 7():32. PubMed ID: 32175331
[TBL] [Abstract][Full Text] [Related]
52. Managing Hyperosmotic Stress through Phase Separation.
Peran I; Sabri N; Mittag T
Trends Biochem Sci; 2020 Sep; 45(9):721-723. PubMed ID: 32446814
[TBL] [Abstract][Full Text] [Related]
53. [Nature of blocking of maturation of erythrocytes responsible for protein-deficiency anemia and role of hormonal balance disorders in its formation].
ASCHKENASY A
J Physiol (Paris); 1955; 47(4):639-43. PubMed ID: 13307445
[No Abstract] [Full Text] [Related]
54. Retraction notice to “Comparative proteomics reveals deficiency of NHE-1 (Slc9a1) in RBCs from the beta-adducin knockout mouse model of hemolytic anemia” [Blood Cells Mol. Dis. 47 (2011) 85–94].
Blood Cells Mol Dis; 2012 Feb; 48(2):145. PubMed ID: 22393569
[No Abstract] [Full Text] [Related]
55. Distinct partitioning of ALS associated TDP-43, FUS and SOD1 mutants into cellular inclusions.
Farrawell NE; Lambert-Smith IA; Warraich ST; Blair IP; Saunders DN; Hatters DM; Yerbury JJ
Sci Rep; 2015 Aug; 5():13416. PubMed ID: 26293199
[TBL] [Abstract][Full Text] [Related]
56. A model for non-obligate oligomer formation in protein aggregration.
Healy EF
Biochem Biophys Res Commun; 2015 Sep; 465(3):523-7. PubMed ID: 26282203
[TBL] [Abstract][Full Text] [Related]
57. Rodent Models of Amyotrophic Lateral Sclerosis.
Philips T; Rothstein JD
Curr Protoc Pharmacol; 2015 Jun; 69():5.67.1-5.67.21. PubMed ID: 26344214
[TBL] [Abstract][Full Text] [Related]
58. Destabilization of the dimer interface is a common consequence of diverse ALS-associated mutations in metal free SOD1.
Broom HR; Rumfeldt JA; Vassall KA; Meiering EM
Protein Sci; 2015 Dec; 24(12):2081-9. PubMed ID: 26362407
[TBL] [Abstract][Full Text] [Related]
59. Structural basis of Cu, Zn-superoxide dismutase amyloid fibril formation involves interaction of multiple peptide core regions.
Ida M; Ando M; Adachi M; Tanaka A; Machida K; Hongo K; Mizobata T; Yamakawa MY; Watanabe Y; Nakashima K; Kawata Y
J Biochem; 2016 Feb; 159(2):247-60. PubMed ID: 26319711
[TBL] [Abstract][Full Text] [Related]
60. Adverse effects of a SOD1-peptide immunotherapy on SOD1 G93A mouse slow model of amyotrophic lateral sclerosis.
Sábado J; Casanovas A; Rodrigo H; Arqué G; Esquerda JE
Neuroscience; 2015 Dec; 310():38-50. PubMed ID: 26384962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
